• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙泊酚注射痛:浓度与稀释剂的影响

Pain on injection of propofol: effects of concentration and diluent.

作者信息

Klement W, Arndt J O

机构信息

Abteilung für Experimentelle Anaesthesiologie, Heinrich-Heine-Universität, Düsseldorf, Germany.

出版信息

Br J Anaesth. 1991 Sep;67(3):281-4. doi: 10.1093/bja/67.3.281.

DOI:10.1093/bja/67.3.281
PMID:1911014
Abstract

The emulsion formulation of propofol (Diprivan) evokes pain on i.v. injection, although its pH and osmolality are close to those of blood. The pain induced by serial dilutions of propofol in Intralipid and 5% glucose was examined in isolated vein segments and after intracutaneous injection. Propofol evoked pain in a concentration-related manner in six of eight subjects after i.v. perfusion and in all eight subjects after intracutaneous injections. Pain was maximal with propofol 56 x 10(-3) mol litre-1 when visual analogue pain scale was 60% of maximum (range 20-92%) for venous perfusion and 89% (range 66-100%) for intracutaneous injection. Dilution with 10% Intralipid reduced pain more than that with 5% glucose. We conclude that the intensity of pain after i.v. injection of propofol was related to its free aqueous concentration.

摘要

丙泊酚(得普利麻)的乳剂配方在静脉注射时会引起疼痛,尽管其pH值和渗透压与血液相近。在离体静脉段和皮内注射后,研究了丙泊酚在脂质乳剂和5%葡萄糖中连续稀释所引起的疼痛。静脉灌注后,8名受试者中有6名,皮内注射后8名受试者全部出现丙泊酚以浓度相关的方式引起疼痛。当视觉模拟疼痛量表为最大值的60%(静脉灌注范围为20 - 92%,皮内注射为89%(范围为66 - 100%))时,丙泊酚浓度为56×10⁻³摩尔/升时疼痛最为剧烈。用10%脂质乳剂稀释比用5%葡萄糖更能减轻疼痛。我们得出结论,静脉注射丙泊酚后的疼痛强度与其游离水相浓度有关。

相似文献

1
Pain on injection of propofol: effects of concentration and diluent.丙泊酚注射痛:浓度与稀释剂的影响
Br J Anaesth. 1991 Sep;67(3):281-4. doi: 10.1093/bja/67.3.281.
2
Sustained intravascular exposure to propofol does not prolong pain at the site of injection.持续血管内注射丙泊酚不会延长注射部位的疼痛时间。
Acta Anaesthesiol Scand. 2007 Apr;51(4):456-9. doi: 10.1111/j.1399-6576.2006.01256.x.
3
Reducing pain during propofol injection: the role of the solvent.减少丙泊酚注射时的疼痛:溶剂的作用。
Anesth Analg. 1996 Mar;82(3):472-4. doi: 10.1097/00000539-199603000-00007.
4
Effect of lignocaine and pH on propofol-induced pain.
Br J Anaesth. 1997 May;78(5):502-6. doi: 10.1093/bja/78.5.502.
5
Comparison on pain on injection of a small particle size-lipid emulsion of propofol and standard propofol with or without lidocaine.丙泊酚小粒径脂质乳剂与标准丙泊酚注射时疼痛情况的比较(有无利多卡因)
J Med Assoc Thai. 2005 Oct;88(10):1401-5.
6
Emulsion of flurbiprofen axetil reduces propofol injection pain due to a decrease in free propofol concentration.氟比洛芬酯乳剂因游离丙泊酚浓度降低而减轻丙泊酚注射痛。
J Anesth. 2007;21(3):325-9. doi: 10.1007/s00540-007-0530-1. Epub 2007 Aug 1.
7
Pain on injection with microemulsion propofol.注射微乳状丙泊酚时出现疼痛。
Br J Clin Pharmacol. 2009 Mar;67(3):316-25. doi: 10.1111/j.1365-2125.2008.03358.x. Epub 2008 Dec 10.
8
Propofol (Diprivan®) and Intralipid® exacerbate insulin resistance in type-2 diabetic hearts by impairing GLUT4 trafficking.丙泊酚(得普利麻)和脂肪乳剂加重 2 型糖尿病心脏胰岛素抵抗,损害葡萄糖转运蛋白 4 转运。
Anesth Analg. 2015 Feb;120(2):329-40. doi: 10.1213/ANE.0000000000000558.
9
Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection.单次注射后,6% SAZN丙泊酚与1% SAZN丙泊酚及得普利麻-10的药代动力学、麻醉诱导及安全性特征
Br J Clin Pharmacol. 1999 Jun;47(6):653-60. doi: 10.1046/j.1365-2125.1999.00942.x.
10
Low-dose propofol reduces the incidence of moderate to severe local pain induced by the main dose.低剂量丙泊酚可降低主剂量引起的中度至重度局部疼痛的发生率。
Acta Anaesthesiol Scand. 2007 Apr;51(4):460-3. doi: 10.1111/j.1399-6576.2006.01255.x.

引用本文的文献

1
Efficacy and safety of ciprofol for sedation/anesthesia in patients undergoing hysteroscopy: a prospective, randomized, non-inferiority trial.环丙泊酚用于宫腔镜手术患者镇静/麻醉的有效性和安全性:一项前瞻性、随机、非劣效性试验。
Ann Med. 2025 Dec;57(1):2517820. doi: 10.1080/07853890.2025.2517820. Epub 2025 Jun 18.
2
Pharmacological mechanism and clinical application of ciprofol.环泊酚的药理机制及临床应用
Front Pharmacol. 2025 Mar 25;16:1572112. doi: 10.3389/fphar.2025.1572112. eCollection 2025.
3
Propofol reduces human TRPA1 activity in a warm environment.
丙泊酚在温暖环境中会降低人类瞬时受体电位锚蛋白1(TRPA1)的活性。
Biochem Biophys Rep. 2025 Jan 27;41:101918. doi: 10.1016/j.bbrep.2025.101918. eCollection 2025 Mar.
4
Comparison of the efficacy and safety of ciprofol and propofol in sedating patients in the operating room and outside the operating room: a meta-analysis and systematic review.比较西普罗和丙泊酚在手术室和手术室外镇静患者的疗效和安全性:一项荟萃分析和系统评价。
BMC Anesthesiol. 2024 Jul 2;24(1):218. doi: 10.1186/s12871-024-02609-3.
5
Efficacy and safety of ciprofol (HSK3486) for procedural sedation and anesthesia induction in surgical patients: A systematic review and meta-analysis.环丙泊酚(HSK3486)用于外科手术患者程序性镇静和麻醉诱导的有效性与安全性:一项系统评价和荟萃分析
Heliyon. 2023 Nov 26;9(12):e22634. doi: 10.1016/j.heliyon.2023.e22634. eCollection 2023 Dec.
6
Efficacy and Safety of Ciprofol for Sedation/Anesthesia in Patients Undergoing Hysteroscopy: A Randomized, Parallel-Group, Controlled Trial.西普罗尔在宫腔镜检查患者镇静/麻醉中的疗效和安全性:一项随机、平行组、对照试验。
Drug Des Devel Ther. 2023 Jun 11;17:1707-1717. doi: 10.2147/DDDT.S414243. eCollection 2023.
7
Hospital Production of Sterile 2% Propofol Nanoemulsion: Proof of Concept.医院生产无菌2%丙泊酚纳米乳剂:概念验证
Pharmaceutics. 2023 Mar 10;15(3):905. doi: 10.3390/pharmaceutics15030905.
8
The efficacy and safety of ciprofol use for the induction of general anesthesia in patients undergoing gynecological surgery: a prospective randomized controlled study.西普罗酚用于妇科手术全身麻醉诱导的疗效和安全性:一项前瞻性随机对照研究。
BMC Anesthesiol. 2022 Aug 3;22(1):245. doi: 10.1186/s12871-022-01782-7.
9
Physicochemical Characterization and Pharmacological Evaluation of Novel Propofol Micelles with Low-Lipid and Low-Free Propofol.新型低脂质和低游离丙泊酚胶束的物理化学表征及药理学评价
Pharmaceutics. 2022 Feb 14;14(2):414. doi: 10.3390/pharmaceutics14020414.
10
Efficacy and Safety of HSK3486 for Anesthesia/Sedation in Patients Undergoing Fiberoptic Bronchoscopy: A Multicenter, Double-Blind, Propofol-Controlled, Randomized, Phase 3 Study.HSK3486 用于纤维支气管镜检查患者麻醉/镇静的有效性和安全性:一项多中心、双盲、丙泊酚对照、随机、3 期研究。
CNS Drugs. 2022 Mar;36(3):301-313. doi: 10.1007/s40263-021-00890-1. Epub 2022 Feb 14.